Pinned
Oct '25 •
Christopher’s Weekly Tea Talks
A live, come-as-you-are conversation about natural kratom and herbal wellness. Join us for Christopher’s Weekly Tea Talks every Thursday at 7 PM EST, where I host a live Zoom session where people can learn about natural kratom, ask questions, connect with others, and hear exactly what is happening in the real world not just in politics or the media, but in the everyday lives of consumers, small businesses, and the farmers who grow this plant. The world of wellness is evolving, and with it comes the necessity for open dialogues about natural remedies. In our discussions, we emphasize the importance of understanding both the benefits and risks associated with herbal supplements, especially kratom. Many individuals are seeking alternatives to traditional pharmaceuticals, and kratom has emerged as a popular choice. It’s crucial to share real-life experiences that highlight both the positive outcomes and the challenges faced by users. During our sessions, we focus on practical advice and real stories from people who have integrated kratom into their lives. This personal touch makes our discussions relatable and informative. We often feature guest speakers who share their journeys with herbal medicine, which adds a diverse perspective to our conversations. This format encourages a deeper exploration of topics that are often overlooked. For instance, we discuss recent research findings on kratom and its potential therapeutic benefits. By examining studies, we equip our community with factual information to make informed decisions. Talk Beyond Just The Headlines Natural kratom has helped countless people reclaim quality of life, yet most of what the public hears comes from headlines, not real humans with real experiences. Christopher’s Weekly Tea Talks is where that changes. Moreover, we aim to demystify kratom by addressing common myths and misconceptions. This awareness is essential in navigating the discourse surrounding kratom, especially in light of regulatory challenges.
13h •
Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2 H -benzo[ d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2 H -benzo[ d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018); 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1 H -benzo[ d]imidazol-1-yl)propanenitrile (commonly known as N -propionitrile chlorphine or cychlorphine); and 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (commonly known as spirochlorphine or R-6890), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these four specific substances.https://www.federalregister.gov/documents/2026/07/01/2026-13364/schedules-of-controlled-substances-temporary-placement-of-56--dichloro-brorphine-56-dichloro
3d •
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine above a specified threshold, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 7-hydroxymitragynine above a specified threshold.https://www.federalregister.gov/documents/2026/07/06/2026-13580/schedules-of-controlled-substance-temporary-placement-of-7-hydroxymitragynine-above-a-specified
2
0
3d •
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.https://www.federalregister.gov/documents/2026/07/06/2026-13581/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and
3
0
3d •
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[ c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine. https://www.federalregister.gov/documents/2026/07/08/2026-13821/schedules-of-controlled-substances-placement-of-tianeptine-in-schedule-i
2
0
1-30 of 133
powered by
skool.com/christophers-kratom-education-8543
Christopher’s Kratom Education: clear, science-based kratom education, beginner walk-throughs, brewing tips, safety, policy, and community together.
Suggested communities
Powered by